Universe Pharmaceuticals (UPC) Competitors $3.56 -0.10 (-2.73%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$3.62 +0.06 (+1.54%) As of 04/17/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock UPC vs. BIOR, ATXI, KRBP, CAPS, TFFP, VRPX, TCBP, ADTX, BON, and HSTOShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Biora Therapeutics (BIOR), Avenue Therapeutics (ATXI), Kiromic BioPharma (KRBP), Capstone (CAPS), TFF Pharmaceuticals (TFFP), Virpax Pharmaceuticals (VRPX), TC Biopharm (TCBP), Aditxt (ADTX), Bon Natural Life (BON), and Histogen (HSTO). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Biora Therapeutics Avenue Therapeutics Kiromic BioPharma Capstone TFF Pharmaceuticals Virpax Pharmaceuticals TC Biopharm Aditxt Bon Natural Life Histogen Universe Pharmaceuticals (NYSE:UPC) and Biora Therapeutics (NASDAQ:BIOR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, community ranking, profitability and risk. Does the MarketBeat Community believe in UPC or BIOR? Biora Therapeutics received 8 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformUniverse PharmaceuticalsN/AN/ABiora TherapeuticsOutperform Votes880.00% Underperform Votes220.00% Is UPC or BIOR more profitable? Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A Biora Therapeutics N/A N/A -332.47% Which has more volatility and risk, UPC or BIOR? Universe Pharmaceuticals has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Comparatively, Biora Therapeutics has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Does the media refer more to UPC or BIOR? In the previous week, Universe Pharmaceuticals' average media sentiment score of 0.00 equaled Biora Therapeutics'average media sentiment score. Company Overall Sentiment Universe Pharmaceuticals Neutral Biora Therapeutics Neutral Do insiders & institutionals have more ownership in UPC or BIOR? 0.2% of Universe Pharmaceuticals shares are held by institutional investors. Comparatively, 43.7% of Biora Therapeutics shares are held by institutional investors. 57.4% of Universe Pharmaceuticals shares are held by company insiders. Comparatively, 51.1% of Biora Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts rate UPC or BIOR? Biora Therapeutics has a consensus price target of $23.00, suggesting a potential upside of 19,524.57%. Given Biora Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Biora Therapeutics is more favorable than Universe Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Universe Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biora Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, UPC or BIOR? Universe Pharmaceuticals has higher revenue and earnings than Biora Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$26.73M0.01-$6.16MN/AN/ABiora Therapeutics$892K0.59-$124.11M-$13.04-0.01 SummaryBiora Therapeutics beats Universe Pharmaceuticals on 6 of the 11 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$153,000.00$6.44B$5.31B$18.41BDividend YieldN/A3.20%5.45%4.19%P/E RatioN/A6.8921.8831.09Price / Sales0.01230.51380.6626.55Price / CashN/A65.6738.2617.53Price / Book0.025.936.454.30Net Income-$6.16M$142.99M$3.22B$1.02B1 Month Performance-9.18%-13.56%-9.75%-8.21%1 Year Performance-99.71%-8.89%11.50%1.69% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$3.56-2.7%N/A-99.7%$153,000.00$26.73M0.00220BIORBiora TherapeuticsN/A$0.12-10.0%$23.00+19,558.1%-98.0%$529,000.00$892,000.00-0.01120Gap UpATXIAvenue Therapeutics2.4465 of 5 stars$0.26-2.0%N/A-97.4%$524,000.00N/A0.014News CoverageGap DownKRBPKiromic BioPharmaN/AN/AN/AN/A$330,000.00N/A-0.0660Gap DownHigh Trading VolumeCAPSCapstoneN/A$1.82-5.2%N/AN/A$303,000.00$44.05M0.0038Quiet Period ExpirationNews CoverageGap DownTFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289,000.00$-70,983.00-0.0119VRPXVirpax Pharmaceuticals1.1281 of 5 stars$0.23-34.2%$75.00+32,466.2%-99.7%$286,000.00N/A0.007Gap DownTCBPTC Biopharm1.2561 of 5 stars$0.68-55.8%$48.00+6,948.5%-99.7%$279,000.00$4.76M0.0080High Trading VolumeADTXAditxt0.237 of 5 stars$3.72-21.4%N/A-100.0%$269,000.00$133,985.000.0060Short Interest ↑Gap DownBONBon Natural LifeN/A$0.07+12.6%N/A-98.7%$266,000.00$23.84M0.00100Gap DownHigh Trading VolumeHSTOHistogenN/A$0.03+3.6%N/A-94.2%$124,000.00$19,000.00-0.0120 Related Companies and Tools Related Companies BIOR Alternatives ATXI Alternatives KRBP Alternatives CAPS Alternatives TFFP Alternatives VRPX Alternatives TCBP Alternatives ADTX Alternatives BON Alternatives HSTO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPC) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UPC Stock Free UPC Stock Alerts